Late-breaking data demonstrate Abbott's FreeStyle Libre® 3 System is more accurate 14-day continuous glucose monitor
Posted in My Blog

Late-breaking data demonstrate Abbott’s FreeStyle Libre® 3 System is more accurate 14-day continuous glucose monitor

Data at the American Diabetes Association 82nd Scientific Sessions shows that Abbott’s FreeStyle Libre® 3 system is the first and…

Abbott announces development of novel continuous glucose-ketone monitoring system
Posted in My Blog

Abbott announces development of novel continuous glucose-ketone monitoring system

Abbott has announced that it is developing a first-of-its-kind biowearable that will continuously monitor glucose and ketone levels in one…

FreeStyle® Libre System provides sustained reductions in glucose levels for people with diabetes, analysis shows
Posted in My Blog

FreeStyle® Libre System provides sustained reductions in glucose levels for people with diabetes, analysis shows

The FreeStyle® Libre system provides significant reductions in HbA1c that are sustained over two years in adults with both type…

New automated insulin delivery system under development
Posted in My Blog

New automated insulin delivery system under development

Three diabetes organisations have joined forces to develop and commercialise an integrated, automated insulin delivery system to improve the lives…

Eversense® E3 Continuous Glucose Monitoring System now available in the US
Posted in My Blog

Eversense® E3 Continuous Glucose Monitoring System now available in the US

A global diabetes care company has launched the next-generation Eversense® E3 Continuous Glucose Monitoring System for people in the US. …